Aimee Crago

Title: Aimee Crago: Innovator in Cancer Diagnostics

Introduction

Aimee Crago is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer diagnostics, particularly in the development of companion diagnostics for CDK4 inhibitors. With a total of 2 patents, her work is paving the way for more effective cancer treatments.

Latest Patents

Aimee's latest patents include "Enigma" and "CDH18 as companion diagnostics for CDK4 inhibitors." These patents focus on the use of biomarkers to assess the likelihood that a CDK4 inhibitor will produce an anti-cancer effect in patients. The disclosures provide methods, compositions, and kits for companion diagnostics, emphasizing the importance of the colocalization of Enigma and CDH18 biomarkers within cancer cells. This innovative approach aims to determine whether a cancer can be effectively treated through CDK4 inhibition.

Career Highlights

Aimee Crago is affiliated with the Memorial Sloan Kettering Cancer Center, where she continues her research and development in cancer diagnostics. Her work is characterized by a commitment to improving patient outcomes through innovative diagnostic methods.

Collaborations

Aimee collaborates with esteemed colleagues, including Marta Kovatcheva and Samuel Singer. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Aimee Crago's contributions to cancer diagnostics through her patents and collaborative efforts highlight her role as a leading inventor in the field. Her work is instrumental in developing more effective treatments for cancer patients.